Articles tagged with Nanomedicine
A five-year, $1.15 million grant supports Northeastern's 'CaNCURE' program, offering 75 undergraduate students hands-on research experience with leading cancer nanomedicine experts. The program aims to address cancer disparities and motivate students to pursue careers in cancer research and clinical practice.
Researchers will use radioactive labelling to track where key materials used in nanomedicines accumulate in the body. This study aims to inform regulation and development of safer nanomedicine options for chronic conditions.
Researchers developed biodegradable nanoparticles that selectively target and resolve inflammation, potentially treating atherosclerosis and neurodegenerative diseases. The nanoparticles release an inflammation-resolving peptide drug, promoting tissue repair and reducing chronic inflammation.
Combining antiangiogenesis drugs with smaller nanomedicines may enhance treatment effectiveness for certain cancers. Vascular normalization temporarily decreases tumor blood vessel diameter, improving drug penetration of smaller particles but not larger molecules.
A realistic look at nanomedicine reveals both promise and perils. While dozens of nano health care products are in use, the field also poses risks of nanoparticle toxicity and unintended interactions.
Researchers at the University of Melbourne have successfully tracked a quantum atom inside a living human cell, paving the way for new drug discovery methods. The sensor detects biological processes at a molecular level, providing critical information about drug delivery and uptake.
The Canadian Institutes of Health Research has awarded $16 million in funding for seven new research projects on regenerative medicine and nanomedicine. These studies aim to develop new therapies and approaches to treat illnesses and diseases, ultimately improving patient outcomes.
The summit explored ways to use nanotechnology in medical imaging and therapy, focusing on targeting diseases such as cancer, neurological conditions, and cardiovascular disease. Experts discussed regulatory frameworks, design considerations, and future directions for this rapidly evolving field.
The University of Texas Health Science Center at Houston's UT nanomedicine project will be tested in space as part of a nationwide competition. The experiment aims to study the diffusion of micro nanoparticles through tiny microchannels, which could aid in developing implantable devices for controlled drug release.
The University of Copenhagen has received funding to establish a new center for pharmaceutical nanotechnology and nanotoxicology, aiming to optimize delivery systems and therapeutic benefits. The center will focus on rational design of nanotechnology materials and tools to improve therapeutic benefit-to-risk ratio.
The Mattel UCLA NanoPediatrics Program will explore the future of personalized medicine for children using nanotechnology. Researchers will develop new diagnostic tools and treatments to improve health outcomes for young patients.
Researchers developed a multistage delivery system to improve injectable drug efficacy, targeting diseased cells and releasing therapeutics in a controlled manner. The system uses mesoporous silicon particles to circumvent biobarriers and deliver diagnostic agents or therapeutic agents.
Researchers at UT Health Science Center have developed a smart particle insulin release system that detects blood sugar spikes and releases insulin to counteract them. The system, which consists of a blood sugar sensing protein and liposomes loaded with insulin, stabilized blood sugar levels in animal models for up to six hours.
Purdue University has been awarded $7 million to study the use of a nanomotor, a microscopic biological machine, for diagnosing and treating diseases like cancer and AIDS. The team will adapt a viral motor to package therapeutic DNA or RNA for disease-causing cells.
The new center will apply advanced engineering techniques and life science knowledge to control molecular interactions in cells, aiming to enhance disease treatment methods. Researchers will investigate optimal drug cocktails and mapping of molecular events that trigger stem cell differentiation.
A $6.5 million nanomedicine center at Yale University aims to design, model, synthesize, and fabricate nanomedical devices based on natural and synthetic ion transporters. The center will focus on developing biobatteries for implantable devices, including an artificial retina.
Researchers are developing functional nanoparticles that can be linked to biological molecules, enabling rapid analysis of biopsy tissue from cancer patients. These nanoprobes using quantum dots can monitor the effectiveness of drug therapy and deliver controlled amounts of drugs into genetically classified tumor cells.
The Lancet calls for increased investment in nanomedicine research, citing its potential to revolutionize disease diagnosis and treatment. The field's benefits include novel means of imaging and delivery systems for drugs and gene therapies.